08:43 AM EDT, 07/26/2024 (MT Newswires) -- Mark Ragosa, CHIEF FINANCIAL OFFICER, on July 23, 2024, sold 24,248 shares in Kiniksa Pharmaceuticals International (KNSA) for $601,108. Following the Form 4 filing with the SEC, Ragosa has control over a total of 19,253 shares of the company, with 19,253 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000141588924020106/xslF345X03/form4-07252024_080736.xml